Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 873

1.

Impact of Historical Changes in Coarse Cereals Consumption in India on Micronutrient Intake and Anemia Prevalence.

DeFries R, Chhatre A, Davis KF, Dutta A, Fanzo J, Ghosh-Jerath S, Myers S, Rao ND, Smith MR.

Food Nutr Bull. 2018 Aug 1:379572118783492. doi: 10.1177/0379572118783492. [Epub ahead of print]

PMID:
30068220
2.

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).

Byrd JC, Ruppert AS, Heerema NA, Halvorson AE, Hoke E, Smith MR, Godwin JE, Couban S, Fehniger TA, Thirman MJ, Tallman MS, Appelbaum FR, Stone RM, Robinson S, Chang JE, Mandrekar SJ, Larson RA.

Blood Adv. 2018 Jul 24;2(14):1705-1718. doi: 10.1182/bloodadvances.2017015396.

3.

Possible Drug-nutraceutical Interaction leading to Unexpected Sequelae after Inguinal Hernia Repair.

Smith MR, Faingold C, Mellinger JD.

Am J Case Rep. 2018 Jul 17;19:836-838. doi: 10.12659/AJCR.908117.

4.

Apalutamide and Metastasis-free Survival in Prostate Cancer.

Smith MR, Yu MK, Small EJ.

N Engl J Med. 2018 Jun 28;378(26):2542. doi: 10.1056/NEJMc1806189. No abstract available.

5.

Progress in Nonmetastatic Prostate Cancer.

Smith MR.

N Engl J Med. 2018 Jun 28;378(26):2531-2532. doi: 10.1056/NEJMe1805733. No abstract available.

PMID:
29949488
6.

Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged Mice.

Hayakawa K, Formica AM, Nakao Y, Ichikawa D, Shinton SA, Brill-Dashoff J, Smith MR, Morse HC 3rd, Hardy RR.

J Immunol. 2018 Jul 15;201(2):804-813. doi: 10.4049/jimmunol.1800400. Epub 2018 Jun 13.

7.

Reply to C. Ren et al.

Heller G, McCormack R, Kheoh T, Molina A, Smith MR, Dreicer R, Saad F, de Wit R, Aftab DT, Hirmand M, Limon-Carrera A, Fizazi K, Fleisher M, de Bono JS, Scher HI.

J Clin Oncol. 2018 Aug 1;36(22):2354-2356. doi: 10.1200/JCO.2018.78.2672. Epub 2018 Jun 12. No abstract available.

PMID:
29894273
8.

Nonmammalian Models of Huntington's Disease.

Chongtham A, Barbaro B, Filip T, Syed A, Huang W, Smith MR, Marsh JL.

Methods Mol Biol. 2018;1780:75-96. doi: 10.1007/978-1-4939-7825-0_5.

PMID:
29856015
9.

Optimal use of novel agents in chronic lymphocytic leukemia.

Smith MR, Weiss RF.

Leuk Res. 2018 May 7;70:37-40. doi: 10.1016/j.leukres.2018.05.001. [Epub ahead of print]

PMID:
29787919
10.

Protein-Scaffold Directed Nanoscale Assembly of T Cell Ligands: Artificial Antigen Presentation with Defined Valency, Density, and Ratio.

Smith MR, Tolbert SV, Wen F.

ACS Synth Biol. 2018 Jun 15;7(6):1629-1639. doi: 10.1021/acssynbio.8b00119. Epub 2018 May 21.

PMID:
29733631
11.

Integrative metabolomics and transcriptomics signatures of clinical tolerance to Plasmodium vivax reveal activation of innate cell immunity and T cell signaling.

Gardinassi LG, Arévalo-Herrera M, Herrera S, Cordy RJ, Tran V, Smith MR, Johnson MS, Chacko B, Liu KH, Darley-Usmar VM, Go YM; MaHPIC Consortium, Jones DP, Galinski MR, Li S.

Redox Biol. 2018 Jul;17:158-170. doi: 10.1016/j.redox.2018.04.011. Epub 2018 Apr 11.

12.

Mental Fatigue and Soccer: Current Knowledge and Future Directions.

Smith MR, Thompson C, Marcora SM, Skorski S, Meyer T, Coutts AJ.

Sports Med. 2018 Jul;48(7):1525-1532. doi: 10.1007/s40279-018-0908-2.

PMID:
29623604
13.

Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant.

Allen J, Ruano Mendez AL, Rybicki L, Sawalha Y, Jagadeesh D, Dean R, Pohlman B, Smith MR, Hsi ED, Hill BT.

Ther Adv Hematol. 2018 Apr;9(4):81-87. doi: 10.1177/2040620718759249. Epub 2018 Mar 29.

14.

In cell mutational interference mapping experiment (in cell MIME) identifies the 5' polyadenylation signal as a dual regulator of HIV-1 genomic RNA production and packaging.

Smyth RP, Smith MR, Jousset AC, Despons L, Laumond G, Decoville T, Cattenoz P, Moog C, Jossinet F, Mougel M, Paillart JC, von Kleist M, Marquet R.

Nucleic Acids Res. 2018 May 18;46(9):e57. doi: 10.1093/nar/gky152.

15.

Shaping a valued learning journey: Student satisfaction with learning in undergraduate nursing programs, a grounded theory study.

Smith MR, Grealish L, Henderson S.

Nurse Educ Today. 2018 May;64:175-179. doi: 10.1016/j.nedt.2018.02.020. Epub 2018 Feb 22.

PMID:
29500998
16.

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.

Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators.

N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8.

PMID:
29420164
17.

An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer.

Miyamoto DT, Lee RJ, Kalinich M, LiCausi JA, Zheng Y, Chen T, Milner JD, Emmons E, Ho U, Broderick K, Silva E, Javaid S, Kwan TT, Hong X, Dahl DM, McGovern FJ, Efstathiou JA, Smith MR, Sequist LV, Kapur R, Wu CL, Stott SL, Ting DT, Giobbie-Hurder A, Toner M, Maheswaran S, Haber DA.

Cancer Discov. 2018 Mar;8(3):288-303. doi: 10.1158/2159-8290.CD-16-1406. Epub 2018 Jan 4.

PMID:
29301747
18.

Mental Fatigue Impairs Physical Performance in Young Swimmers.

Penna EM, Filho E, Wanner SP, Campos BT, Quinan GR, Mendes TT, Smith MR, Prado LS.

Pediatr Exerc Sci. 2018 May 1;30(2):208-215. doi: 10.1123/pes.2017-0128. Epub 2017 Dec 23.

PMID:
29276857
19.

Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials.

Heller G, McCormack R, Kheoh T, Molina A, Smith MR, Dreicer R, Saad F, de Wit R, Aftab DT, Hirmand M, Limon A, Fizazi K, Fleisher M, de Bono JS, Scher HI.

J Clin Oncol. 2018 Feb 20;36(6):572-580. doi: 10.1200/JCO.2017.75.2998. Epub 2017 Dec 22.

20.

Frequency distribution of osteochondral fragmentation of the dorsoproximal articular surface of the proximal phalanx in racing Thoroughbreds in the UK.

Walsh R, Smith MRW, Wright IM.

Equine Vet J. 2017 Dec 12. doi: 10.1111/evj.12795. [Epub ahead of print]

PMID:
29230868
21.

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y, Timmerman JM, Stiff PJ, Friedberg JW, Flinn IW, Goy A, Hill BT, Smith MR, Deol A, Farooq U, McSweeney P, Munoz J, Avivi I, Castro JE, Westin JR, Chavez JC, Ghobadi A, Komanduri KV, Levy R, Jacobsen ED, Witzig TE, Reagan P, Bot A, Rossi J, Navale L, Jiang Y, Aycock J, Elias M, Chang D, Wiezorek J, Go WY.

N Engl J Med. 2017 Dec 28;377(26):2531-2544. doi: 10.1056/NEJMoa1707447. Epub 2017 Dec 10.

22.

Loss-of-function of neuroplasticity-related genes confers risk for human neurodevelopmental disorders.

Smith MR, Glicksberg BS, Li L, Chen R, Morishita H, Dudley JT.

Pac Symp Biocomput. 2018;23:68-79.

23.

Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience.

Sawalha Y, Hill BT, Rybicki LA, Sun D, Dean RM, Jagadeesh D, Hamilton BK, Gerds AT, Sobecks RM, Andresen S, Liu HK, Majhail NS, Pohlman B, Kalaycio ME, Bolwell BJ, Smith MR.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e95-e102. doi: 10.1016/j.clml.2017.11.002. Epub 2017 Dec 6.

PMID:
29208403
24.

Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.

Sartor O, Vogelzang NJ, Sweeney C, Fernandez DC, Almeida F, Iagaru A, Brown A Jr, Smith MR, Agrawal M, Dicker AP, Garcia JA, Lutzky J, Wong YN, Petrenciuc O, Gratt J, Shore ND, Morris MJ; U.S. Expanded Access Program Investigators.

Oncologist. 2018 Feb;23(2):193-202. doi: 10.1634/theoncologist.2017-0413. Epub 2017 Nov 28.

PMID:
29183960
25.

Orthrozanclus elongata n. sp. and the significance of sclerite-covered taxa for early trochozoan evolution.

Zhao F, Smith MR, Yin Z, Zeng H, Li G, Zhu M.

Sci Rep. 2017 Nov 24;7(1):16232. doi: 10.1038/s41598-017-16304-6.

26.

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.

Meixenberger K, Yousef KP, Smith MR, Somogyi S, Fiedler S, Bartmeyer B, Hamouda O, Bannert N, von Kleist M, Kücherer C.

Virol J. 2017 Nov 14;14(1):223. doi: 10.1186/s12985-017-0887-1.

27.

Experiences of women discharged less than 24 hours post vaginal birth: a systematic review protocol.

Cusack L, Smith MR.

JBI Database System Rev Implement Rep. 2017 Nov;15(11):2599-2603. doi: 10.11124/JBISRIR-2017-003411. Review.

PMID:
29135740
28.

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

Armstrong AJ, Antonarakis ES, Taplin ME, Kelly WK, Beltran H, Fizazi K, Dahut WL, Shore N, Slovin S, George D, Carducci MA, Corn P, Danila D, Dreicer R, Heath E, Rathkopf D, Liu G, Nanus D, Stein M, Smith MR, Sternberg C, Wilding G, Nelson PS, Halabi S, Kantoff P, Clarke NW, Evans CP, Heidenreich A, Mottet N, Gleave M, Morris MJ, Scher HI.

Ann Oncol. 2018 Jan 1;29(1):23-25. doi: 10.1093/annonc/mdx648. No abstract available.

PMID:
29088323
29.

Three-way ROC validation of rs-fMRI visual information propagation transfer functions used to differentiate between RRMS and CIS optic neuritis patients.

Farahani ES, Choudhury SH, Cortese F, Costello F, Goodyear B, Smith MR.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:525-528. doi: 10.1109/EMBC.2017.8036877.

PMID:
29059925
30.

Analysis of Radionuclide Deposition Ratios from the Fukushima-Daiichi Incident.

Marianno CM, Smith MR, Cook KM.

Health Phys. 2018 Jan;114(1):13-19. doi: 10.1097/HP.0000000000000725.

PMID:
29049047
31.

Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results.

Tombal B, Borre M, Rathenborg P, Werbrouck P, Van Poppel H, Heidenreich A, Iversen P, Braeckman J, Heracek J, Baron B, Krivoshik A, Hirmand M, Smith MR.

J Urol. 2018 Feb;199(2):459-464. doi: 10.1016/j.juro.2017.08.103. Epub 2017 Sep 1.

PMID:
28867562
32.

Structures of a DNA Polymerase Inserting Therapeutic Nucleotide Analogues.

Schaich MA, Smith MR, Cloud AS, Holloran SM, Freudenthal BD.

Chem Res Toxicol. 2017 Nov 20;30(11):1993-2001. doi: 10.1021/acs.chemrestox.7b00173. Epub 2017 Sep 1.

PMID:
28862449
33.

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.

MacFarlane AW 4th, Jillab M, Smith MR, Alpaugh RK, Cole ME, Litwin S, Millenson MM, Al-Saleem T, Cohen AD, Campbell KS.

Oncoimmunology. 2017 May 19;6(7):e1330235. doi: 10.1080/2162402X.2017.1330235. eCollection 2017.

34.

A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib.

Winter AM, Landsburg DJ, Mato AR, Isaac K, Hernandez-Ilizaliturri FJ, Reddy N, Smith S, Shadman M, Smith MR, Caimi P, Jagadeesh D, Hill BT.

Blood. 2017 Aug 9. pii: blood-2017-05-786988. doi: 10.1182/blood-2017-05-786988. [Epub ahead of print] No abstract available.

PMID:
28794071
35.

Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era.

Mustafa Ali M, Rybicki L, Nomani L, Rouphail B, Dean RM, Hill BT, Jagadeesh D, Pohlman B, Hsi ED, Smith MR.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):797-803. doi: 10.1016/j.clml.2017.07.002. Epub 2017 Jul 13.

PMID:
28789937
36.

Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.

Madanat YF, Rybicki L, Radivoyevitch T, Jagadeesh D, Dean R, Pohlman B, Kalaycio M, Sekeres MA, Smith MR, Hill BT.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):857-862. doi: 10.1016/j.clml.2017.07.003. Epub 2017 Jul 14.

PMID:
28778620
37.

Gender differences in the earnings produced by a middle range education: The case of Canadian 'colleges'.

Smith MR, Waite S, Durand C.

Soc Sci Res. 2017 Aug;66:140-153. doi: 10.1016/j.ssresearch.2017.03.003. Epub 2017 Mar 19.

PMID:
28705352
38.

A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.

Hill BT, Smith MR, Shelley M, Jagadeesh D, Dean RM, Pohlman B, Sweetenham JW, Bolwell BJ, Smith SD.

Leuk Lymphoma. 2018 Mar;59(3):690-694. doi: 10.1080/10428194.2017.1347932. Epub 2017 Jul 11.

PMID:
28696812
39.

Left ventricular outflow tract velocity time integral outperforms ejection fraction and Doppler-derived cardiac output for predicting outcomes in a select advanced heart failure cohort.

Tan C, Rubenson D, Srivastava A, Mohan R, Smith MR, Billick K, Bardarian S, Thomas Heywood J.

Cardiovasc Ultrasound. 2017 Jul 3;15(1):18. doi: 10.1186/s12947-017-0109-4.

40.

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.

Rathkopf DE, Smith MR, Ryan CJ, Berry WR, Shore ND, Liu G, Higano CS, Alumkal JJ, Hauke R, Tutrone RF, Saleh M, Chow Maneval E, Thomas S, Ricci DS, Yu MK, de Boer CJ, Trinh A, Kheoh T, Bandekar R, Scher HI, Antonarakis ES.

Ann Oncol. 2017 Sep 1;28(9):2264-2271. doi: 10.1093/annonc/mdx283.

PMID:
28633425
41.

Impact of comorbidities on outcomes of elderly patients with diffuse large B-cell lymphoma.

Saygin C, Jia X, Hill B, Dean R, Pohlman B, Smith MR, Jagadeesh D.

Am J Hematol. 2017 Oct;92(10):989-996. doi: 10.1002/ajh.24819. Epub 2017 Jul 19.

PMID:
28612386
42.

In Situ Industrial Bimetallic Catalyst Characterization using Scanning Transmission Electron Microscopy and X-ray Absorption Spectroscopy at One Atmosphere and Elevated Temperature.

Prestat E, Kulzick MA, Dietrich PJ, Smith MM, Tien ME, Burke MG, Haigh SJ, Zaluzec NJ.

Chemphyschem. 2017 Aug 18;18(16):2151-2156. doi: 10.1002/cphc.201700425. Epub 2017 Jul 4.

43.

Parasagittal fractures of the proximal phalanx in Thoroughbred racehorses in the UK: Outcome of repaired fractures in 113 cases (2007-2011).

Smith MRW, Corletto FC, Wright IM.

Equine Vet J. 2017 Nov;49(6):784-788. doi: 10.1111/evj.12707. Epub 2017 Jul 6.

PMID:
28556936
44.

Ir-Catalyzed ortho-Borylation of Phenols Directed by Substrate-Ligand Electrostatic Interactions: A Combined Experimental/in Silico Strategy for Optimizing Weak Interactions.

Chattopadhyay B, Dannatt JE, Andujar-De Sanctis IL, Gore KA, Maleczka RE Jr, Singleton DA, Smith MR 3rd.

J Am Chem Soc. 2017 Jun 14;139(23):7864-7871. doi: 10.1021/jacs.7b02232. Epub 2017 May 31.

45.

Capturing a mammalian DNA polymerase extending from an oxidized nucleotide.

Whitaker AM, Smith MR, Schaich MA, Freudenthal BD.

Nucleic Acids Res. 2017 Jun 20;45(11):6934-6944. doi: 10.1093/nar/gkx293.

46.

As Precious as Platinum: Iron Nitride for Electrocatalytic Oxidation of Liquid Ammonia.

Little DJ, Edwards DO, Smith MR 3rd, Hamann TW.

ACS Appl Mater Interfaces. 2017 May 17;9(19):16228-16235. doi: 10.1021/acsami.7b02639. Epub 2017 May 3.

PMID:
28447778
47.

Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.

Martin P, Chen Z, Cheson BD, Robinson KS, Williams M, Rajguru SA, Friedberg JW, van der Jagt RH, LaCasce AS, Joyce R, Ganjoo KN, Bartlett NL, Lemieux B, VanderWalde A, Herst J, Szer J, Bar MH, Cabanillas F, Dodds AJ, Montgomery PG, Pressnail B, Ellis T, Smith MR, Leonard JP.

Br J Haematol. 2017 Jul;178(2):250-256. doi: 10.1111/bjh.14667. Epub 2017 Apr 17.

48.

Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakes.

Beal T, Massiot E, Arsenault JE, Smith MR, Hijmans RJ.

PLoS One. 2017 Apr 11;12(4):e0175554. doi: 10.1371/journal.pone.0175554. eCollection 2017.

49.

Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.

Smith MR, Saad F, Rathkopf DE, Mulders PFA, de Bono JS, Small EJ, Shore ND, Fizazi K, Kheoh T, Li J, De Porre P, Todd MB, Yu MK, Ryan CJ.

Eur Urol. 2017 Jul;72(1):10-13. doi: 10.1016/j.eururo.2017.03.007. Epub 2017 Mar 15.

PMID:
28314611
50.

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis.

Sidana S, Narkhede M, Elson P, Hastings D, Faiman B, Valent J, Samaras C, Hamilton K, Liu HK, Smith MR, Reu FJ.

PLoS One. 2017 Mar 9;12(3):e0172996. doi: 10.1371/journal.pone.0172996. eCollection 2017.

Supplemental Content

Loading ...
Support Center